Allergan Recalls Textured Breast Implants Worldwide

July 26, 2019

Allergan Plc said on Wednesday it was recalling its Biocell textured breast implants and tissue expanders across markets, citing concerns over a rare form of cancer, after the U.S. health agency asked the drugmaker to pull the products.The Food And Drug Administration found the use of these breast implants was tied to increased risk of a rare type of cancer known as breast-implant associated anaplastic large cell lymphoma (BIA-ALCL).Read more at Reuters >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform
    • TITAN Aesthetic Founder Mary Beth Hagen Transfers Ownership to Carrie Galpin
    • AmSpa’s Medical Spa Show Voted Best Tradeshow Injectable Education
    • Ohio Med Spa Fined $25,000 Following Prescription Drug Violations Investigation
    • Mississippi Boards Warn Against Use of ‘Research-Grade’ Peptides